Related Experiment Videos
Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs
Lancet (London, England)
|February 14, 1976
Insights
Accumulation of cyclic adenosine 3
Area of Science:
- Cardiology and Molecular Biology
Background:
- Ventricular fibrillation is a life-threatening arrhythmia.
- Ischaemic heart disease and myocardial infarction are major causes of cardiac events.
Purpose of the Study:
- To propose a link between cyclic adenosine 3',5' monophosphate (cyclic A.M.P.) accumulation and ventricular fibrillation.
- To provide a framework for understanding antiarrhythmic drug actions.
Main Methods:
- Review of existing literature on the electrophysiological and metabolic actions of cyclic A.M.P.
- Hypothesis formulation based on known scientific principles.
Main Results:
- Cyclic A.M.P. accumulation in the ischaemic zone is proposed as a mechanism for ventricular fibrillation.
- The hypothesis aligns with the known actions of cyclic A.M.P.
Conclusions:
- Cyclic adenosine 3',5' monophosphate (cyclic A.M.P.) accumulation may play a key role in the development of ventricular fibrillation during myocardial infarction.
- This hypothesis offers a new perspective on the mechanism of action for antiarrhythmic drugs.
Abstract:
It is proposed that the development of ventricular fibrillation in the context of ischaemic heart-disease and myocardial infarction can be related to accumulation of cyclic adenosine 3',5' monophosphate (A.M.P.) in the ischaemic zone. The known electrophysiological and metabolic actions of cyclic A.M.P. are consonant with the hypothesis, which also provides a framework for the better understanding of the action of antiarrhythmic drugs.